DaVita (DVA) Tops Q1 EPS by 9c
DaVita (NYSE: DVA) reported Q1 EPS of $1.02, $0.09 better than the analyst estimate of $0.93. Revenue for the quarter came in at $2.85 billion versus the consensus estimate of $2.78 billion.
The following forward-looking measures and the underlying assumptions involve significant risks and uncertainties, including those described herein, and actual results may vary significantly from these current forward-looking measures. The guidance below does not include the impact of currency fluctuations.
- We still expect our Kidney Care consolidated operating income for 2018 to be in the range of $1.5 billion to $1.6 billion.
- We still expect our operating cash flow from continuing operations for 2018 to be in the range of $1.4 billion to $1.6 billion.
- We still expect our 2018 effective tax rate attributable to DaVita Inc. to be approximately 26.5% to 27.5%.
For earnings history and earnings-related data on DaVita (DVA) click here.